FGF23 and left ventricular hypertrophy: Thus, based on current available data we hypothesize that FGF23 predicts cardiovascular outcomes in CKD mainly by portraying vascular stress due to parallel changes in mineral metabolism and by directly promoting left ventricular hypertrophy (LVH) [10].